De Carlis L, Pirotta V, Rondinara G F, Sansalone C V, Colella G, Maione G, Slim A O, Rampoldi A, Cazzulani A, Belli L, Forti D
Department of Surgery and Abdominal Transplantation, Niguarda Hospital, Milan, Italy.
Liver Transpl Surg. 1997 Mar;3(2):160-5. doi: 10.1002/lt.500030209.
Focal nodular hyperplasia (FNH) and adenoma are rare benign hepatic tumors, and the standards for diagnosis and treatment still remain controversial. Usually adenoma is an indication for resection, due to its tendency to bleed and to degenerate; FNH, on the contrary, may be treated conservatively. Preoperation differential diagnosis is, however, difficult, often impossible.
Thirty-eight patients with presumed hepatic adenoma and/or FNH were studied at our department from 1984 to 1996. Preoperative assessment included clinical evaluation and symptoms, laboratory tests, liver biopsy, ultrasound scan, computed tomography scan, magnetic resonance imaging, scintigraphy, and angiography. Thirteen patients had a presumed diagnosis of FNH, 16 of adenoma, and 9 of undetermined benign lesions; 27 had hepatic resections (3 with laparoscopic technique), and 11 were not operated on and are actually under a strict follow-up observation.
The final diagnosis was 19 FNH and 19 adenomas (2 of which contained areas of hepatocarcinoma). Presumed diagnosis was confirmed in 71% of cases. Use of oral contraceptives, abdominal symptoms, and pathologic liver test results were frequent in patients with adenomas. There were no deaths after surgery. All resected patients were tumor free during the follow-up, and in 10 of the 11 nonoperated cases, the size of the nodules remained unchanged. We conclude that precise diagnosis of these benign liver tumors remains difficult and sometimes impossible, despite new imaging techniques. Hepatic resections can be performed under very safe conditions; laparoscopic surgery may play a role in selected cases. Adenomas and uncertain cases are clear indications for surgery. Only when a diagnosis of FNH can be firmly confirmed in asymptomatic patients is strict observation without surgery recommended.
局灶性结节性增生(FNH)和腺瘤是罕见的肝脏良性肿瘤,其诊断和治疗标准仍存在争议。通常,腺瘤因有出血和退变倾向而需手术切除;相反,FNH可采用保守治疗。然而,术前鉴别诊断困难,常常无法做到。
1984年至1996年,我们科室对38例疑似肝脏腺瘤和/或FNH的患者进行了研究。术前评估包括临床评估与症状、实验室检查、肝活检、超声扫描、计算机断层扫描、磁共振成像、闪烁扫描和血管造影。13例患者被初步诊断为FNH,16例为腺瘤,9例为未明确的良性病变;27例行肝脏切除术(3例采用腹腔镜技术),11例未手术,实际处于严密随访观察中。
最终诊断为19例FNH和19例腺瘤(其中2例含有肝癌区域)。71%的病例初步诊断得到证实。腺瘤患者中经常出现口服避孕药使用史、腹部症状和肝脏病理检查结果异常。术后无死亡病例。所有接受手术切除的患者在随访期间均无肿瘤复发,11例未手术病例中有10例结节大小未变。我们得出结论,尽管有新的成像技术,这些肝脏良性肿瘤的精确诊断仍然困难,有时甚至无法做到。肝脏切除术可在非常安全的条件下进行;腹腔镜手术在某些特定病例中可能发挥作用。腺瘤和诊断不明确的病例明确提示需手术治疗。只有在无症状患者中能够明确确诊为FNH时,才建议严密观察而不进行手术。